David C. Ott, 10% Owner at Roivant Sciences Ltd. (ROIV), sold 26,000,000 shares at $9.90 ($257.4M) on 2023-06-22, disclosed to the SEC on 2023-06-26.
Open-market sale of $257.4M ROIV by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.90 | 110,756 | $1.1M | 0.4% |
| 2 | $9.90 | 110,756 | $1.1M | 0.4% |
| 3 | $9.90 | 2,226,195 | $22.0M | 8.6% |
| 4 | $9.90 | 2,226,195 | $22.0M | 8.6% |
| 5 | $9.90 | 5,236,006 | $51.8M | 20.1% |
| 6 | $9.90 | 5,236,006 |
| $51.8M |
| 20.1% |
| 7 | $9.90 | 5,427,043 | $53.7M | 20.9% |
| 8 | $9.90 | 5,427,043 | $53.7M | 20.9% |
| Total | $9.90 avg | 26,000,000 | $257.4M | 100% |
| Filing → |
| FLAC | BUY | 2022-11-04 | $17.1M | — | Filing → |
| INBX | BUY | 2022-10-12 | $40.0M | — | Filing → |
| FDMT | BUY | 2020-12-17 | $25.3M | — | Filing → |